Changes to Lysine supply in the EU: Be ready for the transition

Changes-to-Lysine-supply-in-the-EU-Be-ready-for-the-transition.jpg
© GettyImages/Moussa81 (Getty Images/iStockphoto)

New EU regulation re-authorizing the various forms of the essential amino acid, Lysine, that can be placed on the EU market brings plenty of changes, says Didier Jans, managing director, SERRPA, a consultancy specialized in regulatory and public affairs.

The responsibility to comply with the rules lays of course on the supplier, but according to the EU General Food Law, the user is responsible as well. “No-one can hide behind the supply chain,” said Jans.

A critical element of the new authorization package is that it is now specified from which microorganism strain each form of lysine can be manufactured, said the consultant.

The authorized strains are proprietary - in total, six global producers share the various authorizations granted, said Jans. Those producers are now harvesting the fruit of their applications, which they tabled and supported throughout the EFSA assessment over the last 10 years, he noted.

Smooth transition 

The new regulation includes provisions intended to facilitate a smooth transition, for both Lysine suppliers and for the users, he said. The new authorizations have been in place since December 2019, but Lysine (preparations or premixtures) produced according to the previous regulation can still be placed on the EU market until June 18, 2020, he added.

According to the EU law, this implies that the product must physically exist at the time of the transaction, said Jans.

As far as compound feed is concerned, companies can integrate the previous Lysine forms if the feed is manufactured and labelled before December 18, 2020 and December 2021 for non-food producing animals, he said.

The case of Lysine sulphate is a bit more restrictive, said Jans.

“In this case the former authorization was already restricted to production through fermentation with Corynebacterium glutamicum. L-lysine sulphate produced with a microorganism species other than Corynebacterium glutamicum (e.g. Escherichia coli) cannot benefit from the transition regime, and, in fact, is illegal, except if produced with Escherichia coli strain CGMCC3705 that was duly authorized through Regulation (EU) 2017/439).”

Summary table of Lysine authorizations under Regulation 1831/2003 and comparison to previous ones under Directive 88/485/EEC

Traceability checks

Compared to the previous situation, the conditions of use and labelling requirements have evolved, he said.

“One of the important compliance aspects then relates to the microorganism strains. This traceability information must be secured and communicated through the value chain. Although it is not a formal labelling requirement, some producers have already decided to include the strain identification (deposit code) into their product label as a part of the product identity.

“The June 18 deadline is approaching rapidly; it is advisable for any concerned supplier/user to take action to secure future supplies.”

Additional traceability checks might be secured as suggested in the toolbox below, said the consultant.